1. South Korea Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Xiangyu Medical Co.,Ltd

Xiangyu Medical Co.,Ltd

688626.SS
Xiangyu Medical Co.,LtdCN flagShanghai Stock Exchange
50.95
CNY
+0.15
- -
7.86BMarket Cap
Xiangyu Medical Co.,Ltd
688626.SS
(Shanghai Stock Exchange)

Recent

price

50.45

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
2.99
3.55
4.14
3.5
3.08
4.72
4.77
5.01
5
Revenue per Share
- -
0.67
1.07
1.64
1.35
0.79
1.44
0.66
0.51
0.53
Basic EPS, GAAP
- -
0.56
1.12
0.64
0.21
-0.1
-1.59
-1.67
-0.64
-2.53
Free Cash Flow per Basic Share
- -
- -
- -
0.01
0.4
0.38
0.26
0.55
0.29
0.28
Dividend per Share
- -
1.1
2.06
3.59
3.96
4.08
5.17
5.36
5.72
5.45
Book Value per Share
- -
3.17
4.17
5.78
11.61
10.93
12.04
11.78
12.12
11.78
Tangible Book Value per Share
- -
120
121
120
150
159
158
156
153
153
Basic Weighted Avg Shares
289
359
427
496
523
489
745
744
768
765
Sales/Revenue/Turnover
27.28
25.88
33.85
43.34
36.87
20.74
29.62
13.01
8.58
9.72
Operating Margin (%)
7
9
10
11
11
16
18
40
56
- -
Depreciation Expense
64
80
129
196
202
125
227
103
78
82
Net Income, GAAP
16.11
14.44
12.56
12.02
10.41
7.29
6.44
4.09
- -
6.39
Effective Tax Rate (%)
22.3
22.38
30.18
39.61
38.57
25.68
30.5
13.85
10.18
10.68
Profit Margin (%)
-18
287
404
471
1,535
1,317
822
407
535
237
Working Capital
- -
- -
- -
- -
- -
- -
8
11
88
10
LT Debt
99
415
547
743
1,946
1,940
2,107
2,055
2,080
2,023
Total Equity
- -
28.72
25.64
27.48
12.49
4.79
10.03
4.05
- -
2.84
Return on Invested Capital (%)
- -
73.9
65.63
54.05
37.78
19.99
29.58
10.21
- -
7.11
Return on Capital (%)
- -
77.43
67.87
57.9
39.55
20.25
31.05
12.46
9.12
10.06
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
355
581
617
LT Borrowings
- -
- -
- -
LT Finance Leases
11
11
10
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
160
160
160
Market Capitalization
4,594
5,569
6,735

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
1,142
1,305
1,289
Cash, Cash Equivalents & STI
743
871
849
Accounts Receivable, Net
65
70
63
Inventories
238
257
266
Total Current Liabilities
735
919
1,053
Payables & Accruals
- -
- -
- -
ST Debt
355
581
617
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
33.77%
1.24%
Free Cash Flow
- -
233.38%
-62.59%
Net Income, GAAP
- -
-6.54%
-24.08%
Sales/Revenue/Turnover
- -
10.9%
3.26%
Total Cash Common Dividend
- -
1,461.03%
-48.09%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
169
169
169
237
744
2025
186
173
231
- -
768
2026
193
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.25
- -
- -
- -
0.66
2025
0.15
- -
- -
- -
0.51
2026
0.16
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.55
2025
0.05
- -
- -
- -
0.29
2026
0.01
- -
- -
- -
- -
Similar Companies
Abbott Laboratories (ABT)
Beyond Air, Inc. (XAIR)
Nihon Kohden Corporation (NHNKY)
Beijing Succeeder Technology Inc. (688338.SS)
FUJIFILM Holdings Corporation (4901.T)
Misonix, Inc. (MSON)
Business
Xiangyu Medical Co., Ltd is a China-based company primarily engaged in the research, development, manufacture, and sale of medical devices and equipment. Its core product offerings include a comprehensive portfolio of medical consumables, surgical instruments, hospital furniture, diagnostic systems, and healthcare-related materials. The company serves a broad customer base across healthcare institutions, clinics, and health management organizations in China and internationally. Founded in 2004 and headquartered in Zhengzhou, Henan Province, Xiangyu Medical operates within the medical device and healthcare industry with a focus on high-quality, innovative medical products. In recent years, Xiangyu Medical has expanded its product innovation pipeline and strengthened strategic partnerships to enhance its market presence and competitiveness. The company has introduced new product lines catering to evolving clinical needs and scaled its operations through acquisitions and collaborations with medical research institutes. It has actively pursued product diversification and business expansion within China and other key markets to capture growing demand in medical consumables and advanced healthcare technology sectors. These major initiatives reflect Xiangyu Medical's ongoing commitment to sustainable growth and technological advancement in the medical device industry. Overall, Xiangyu Medical Co., Ltd stands as a leading integrated supplier of medical devices with a robust product range encompassing consumables, diagnostics, surgical instruments, and hospital equipment. Its strategic developments in product innovation and market expansion underscore its position as a significant player in China’s healthcare sector and its growing influence internationally. The company continues to leverage partnerships, research and development, and operational enhancements to support its business growth trajectory.